• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

anthracycline

	Next higher product group	cancer drug

Record changed: 2017-04-01

Advertisement

More documents for anthracycline

• [1] Novartis AG. (9/20/17). "Press Release: Novartis Drug Rydapt (midostaurin) Receives EU Approval for Newly Diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) and Three Types of Advanced Systemic Mastocytosis (SM)". Basel....
• [2] Roche. (9/11/17). "Press Release: Onxeo Announces Top-line Results from ReLive Phase III Study of Livatag in Advanced Hepatocellular Carcinoma". Paris....
• [3] Onxeo S.A.. (6/20/17). "Press Release: Onxeo Successfully Raises €15 Million with US and European Investors [Not for distribution in the United States, Canada, Australia and Japan]". Paris....
• [4] Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris....
• [5] Onxeo S.A.. (10/25/16). "Press Release: Onxeo Reports Third Quarter 2016 Financial Information and Provides Business Update". Paris & Copenhagen....
• [6] Ergomed plc. (10/14/16). "Press Release: Ergomed’s Co-development Partner Aeterna Zentaris, Inc. Announces a Fourth Licensing Agreement for Zoptrex". London....
• [7] Onxeo S.A.. (9/30/16). "Press Release: Onxeo Raises €12.5 Million through Capital Increase with US and European Investors [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen....
• [8] Onxeo S.A.. (9/29/16). "Press Release: Onxeo Launches Capital Increase [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen....
• [9] Onxeo S.A.. (9/12/16). "Press Release: Onxeo Announces First Outcomes of Livatag Preclinical Plan". Paris & Copenhagen....
• [10] PharmaMar S.A.. (8/2/16). "Press Release: PharmaMar Initiates a Pivotal Phase III ATLANTIS Study with PM1183 in Combination with Doxorubicin in Patients with Small Cell Lung Cancer". Madrid....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.